AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB – QNT Press Release4 years ago
SEDG BREAKING ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages SolarEdge Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SEDG – QNT Press Release4 years ago
BetDEX Exchange to Launch on Solana Mainnet Ahead of 2022 FIFA World Cup – QNT Press Release4 years ago
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages US Bancorp Investors to Secure Counsel Before Important Deadline in Securities Class Action – USB – QNT Press Release4 years ago
